Registered Number:12114233 |
For the year ended 31 July 2023
England and Wales
Unaudited Financial Statements
For the year ended 31 July 2023
Sanapharm Limited
Contents Page
1
Statement of Financial Position
2 to 3
Notes to the Financial Statements
Sanapharm Limited
Statement of Financial Position
2022
2023
Property, plant and equipment |
125
250
2
-
1
3
126
250
Trade and other receivables |
-
286
4
24,941
Cash and cash equivalents |
5,598
5,884
24,941
Trade and other payables: amounts falling due within one |
year |
(16,536)
(5,225)
5
8,405
659
Net current assets
Total assets less current liabilities |
785
8,655
785
Net assets
8,655
100
100
685
8,555
785
8,655
Shareholders' funds
For the year ended 31 July 2023 the company was entitled to exemption from audit under Section 477 of the Companies Act 2006 relating to small companies. |
The members have not required the company to obtain an audit of its financial statements for the year ended 31 July 2023 in accordance with Section 476 of the Companies Act 2006 |
The director acknowledges her responsibilities for:a) ensuring that the company keeps proper accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
b) preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of |
each financial year and of its profit or loss for each financial year in accordance with the requirements of Section |
394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial |
statements, so far as applicable to the company. |
In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered. |
The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. |
These financial statements were approved and authorised for issue by the Board on 15 April 2024 and were signed by: |
The notes form part of these financial statements |
1 of 3
For the year ended 31 July 2023
Sanapharm Limited
Notes to the Financial Statements
Statutory Information
Sanapharm Limited is a private limited company, limited by shares, domiciled in England and Wales, registration |
number 12114233. |
51 Tennis Court Drive
Leicester
LE5 1AS
The presentation currency is £ sterling. |
Basis of preparing the financial statements
These financial statements have been prepared in accordance with the provisions of Section 1A of Financial |
Reporting Standard 102 ''The Financial Reporting Standard applicable in the UK and Republic of Ireland'' and the |
Companies Act 2006. The financial statements have been prepared under the historical costs convention as |
modified by the revaluation of certain assets. |
2. Property, plant and equipment |
500
500
Provision for depreciation and impairment |
250
Charge for year
125
375
125
250
2 of 3
For the year ended 31 July 2023
Sanapharm Limited
Notes to the Financial Statements Continued
3. Investments held as fixed assets |
1
1
1
1
1
1
4. Trade and other receivables |
2022
2023
286
-
5. Trade and other payables: amounts falling due within one year |
2022
2023
Taxation and social security |
-
2,277
5,225
14,259
5,225
16,536
6. Average number of persons employed |
During the year the average number of employees was 1 (2022 : 2)
3 of 3